MDA
GSK icon

Minot DeBlois Advisors’s GSK GSK Stock Holding History

Minot DeBlois Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.1K Buy
600
+520
+650% +$28.2K 0.03% 118
2025
Q4 		$3.92K Sell
80
-520
-87% -$24.3K ﹤0.01% 170
2025
Q3 		$25.9K Hold
600
– – 0.02% 126
2025
Q2 		$23K Hold
600
– – 0.02% 131
2025
Q1 		$23.2K Hold
600
– – 0.02% 134
2024
Q4 		$20.3K Buy
+600
New +$21.6K 0.02% 170

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Minot DeBlois Advisors's GSK Position: Q1 2026 in Review

Minot DeBlois Advisors increased its GSK (GSK) stake by 650% in Q1 2026, buying an estimated $28.2K and bringing the position to 600 shares worth $33.1K. The position accounts for 0.03% of the portfolio, ranked #118.

Minot DeBlois Advisors first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Minot DeBlois Advisors held 600 shares of GSK worth $33.1K as of Q1 2026.
  • Minot DeBlois Advisors bought 520 GSK shares in Q1 2026, an estimated $28.2K.
  • GSK made up 0.03% of Minot DeBlois Advisors's portfolio in Q1 2026, its #118 holding.
  • Minot DeBlois Advisors first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Minot DeBlois Advisors's 13F filing for Q1 2026, filed 8 May 2026.